{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:18:46Z","timestamp":1791209926661,"version":"4.1.0"},"reference-count":9,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T00:00:00Z","timestamp":1232496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1111\/j.1365-2125.2009.03369.x","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T16:51:06Z","timestamp":1232556666000},"page":"494-502","source":"Crossref","is-referenced-by-count":51,"title":["Orphan drug development is not taking off"],"prefix":"10.1111","volume":"67","author":[{"given":"Roberta","family":"Joppi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Bertele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Garattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60872-7"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60847-8"},{"key":"e_1_2_8_4_2","first-page":"1","article-title":"Regulation (EC) No 141\/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products","volume":"18","year":"2000","journal-title":"Official Journal of the European Communities"},{"key":"e_1_2_8_5_2","unstructured":"Committee for Proprietary Medicinal Products.Note for Guidance on Repeated Dose Toxicity. July 2000. Available athttp:\/\/www.emea.europa.eu\/pdfs\/human\/swp\/104299en.pdf(last accessed 21 March 2008)."},{"key":"e_1_2_8_6_2","unstructured":"Committee for Proprietary Medicinal Products.Note for guidance on duration of chronic toxicity testing in animals (rodent and non rodent toxicity testing). May 1999. Available athttp:\/\/www.emea.europa.eu\/pdfs\/human\/ich\/030095en.pdf(last accessed 26 November 2008)."},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60876-4"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02579.x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02617.x"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0454-6"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.2009.03369.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.2009.03369.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:11:14Z","timestamp":1697429474000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.2009.03369.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,24]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1365-2125.2009.03369.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.2009.03369.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,24]]}}}